NSE: NH · 13 November 2026
- Narayana Hrudayalaya Ltd. shares advanced 1.10% on Thursday, trading near the upper end of their intraday range. The stock opened at ₹1,840.00, touched a high of ₹1,876.00, and recorded a low of ₹1,833.00 before settling at ₹1,860.40.
- Narayana Hrudayalaya filed the National Company Law Tribunal Bengaluru Bench order sanctioning the Scheme of Arrangement between its wholly owned subsidiary, NH Integrated Care Private Limited, and the parent company, with an appointed date of April 1, 2025. The scheme involves the demerger of 9 clinics in Bengaluru and 1 clinic in Hosur into the main company on a going-concern basis. Since the demerged entity is a wholly owned subsidiary, no new shares will be issued as consideration, leaving the company's share capital unchanged.
- Trading volume was 0.73 times the 20-day average daily volume.
Why is Narayana Hrudayalaya share price rising on 13 November 2026?
Narayana Hrudayalaya Ltd. shares advanced 1.10% on Thursday, trading near the upper end of their intraday range. The stock opened at ₹1,840.00, touched a high of ₹1,876.00, and recorded a low of ₹1,833.00 before settling at ₹1,860.40.
The broader market faced downward pressure during the session, with the Nifty falling 0.61% and the Nifty Pharma sector index declining 0.49%. Despite the weak sectoral backdrop, the stock managed a positive move, though it follows a short-term corrective phase that included a 2.88% loss over the preceding 5 trading days.
The positive price action coincides with recent developments, including the filing of the National Company Law Tribunal order sanctioning the demerger of clinical services from its wholly owned subsidiary into the parent company, alongside steady operational milestones reported for the second quarter of fiscal 2027. However, no single exchange-notified event can be directly tied as an immediate catalyst for today's specific price movement, which appears to reflect routine positioning.
1.23 lakh shares traded by 13 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 1.68 lakh shares (0.73 times). The five-day average daily volume was 1.24 lakh shares. Separately, the NSE report for 13 November 2026 showed 66,668 shares delivered, representing 54.36% of that day’s traded volume. The same report recorded 11,443 trades.
The stock gained 1.10% against a falling broader market and sector, despite below-average trading volume. With no same-day catalyst reported, the move lacks direct causal evidence and is best interpreted as isolated price resilience following recent consolidation.
Latest Company Developments
Narayana Hrudayalaya filed the National Company Law Tribunal Bengaluru Bench order sanctioning the Scheme of Arrangement between its wholly owned subsidiary, NH Integrated Care Private Limited, and the parent company, with an appointed date of April 1, 2025. The scheme involves the demerger of 9 clinics in Bengaluru and 1 clinic in Hosur into the main company on a going-concern basis. Since the demerged entity is a wholly owned subsidiary, no new shares will be issued as consideration, leaving the company's share capital unchanged.
Consolidates clinical care assets directly under the parent entity to streamline operational structures without diluting equity.
The company announced that Dr. Devi Prasad Shetty, Founder and Chairman, was conferred the distinction of Knight of the French National Order of Merit by the French Republic during a ceremony in Bengaluru. The honor recognizes his contributions and support extended to the French community and consulate during the COVID-19 pandemic.
Highlights institutional and international recognition for leadership, contributing to corporate reputation.
Following the recommendation of the audit committee, the board approved the appointment of M/s. B S R & Co. LLP as statutory auditors for a term of five consecutive years. This appointment is scheduled to take effect from the conclusion of the 27th Annual General Meeting in 2027, following the retirement of current auditors Deloitte Haskins & Sells LLP upon completion of their second term.
Ensures seamless audit transition and regulatory continuity for future financial reporting cycles.
'Conferment of the French National Order of Merit on Dr. Devi Prasad Shetty, Founder and Chairman'.
a press release dated October 30, 2026, titled "Narayana Hrudayalaya Limited announces Q2 FY27 results".
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 8.64% on 30 September 2026. This compares with 7.34% on 30 June 2026, a change of +1.30 percentage points.
The filing reported 27 MF/UTI holders.
Research & Brokerage Views
Kotak upgraded the stock to a Buy rating reflecting positive fundamental coverage.
What to Watch Next
- Execution progress of the NCLT-sanctioned demerger of clinical services from the wholly owned subsidiary
- Operational performance and bed utilization metrics at newly launched facilities
- Cash volume and delivery participation trends relative to the 20-day average volume
Other Dated Coverage
More Narayana Hrudayalaya news and dated analysis →
Frequently Asked Questions
What is the latest Narayana Hrudayalaya company news?
Narayana Hrudayalaya filed the National Company Law Tribunal Bengaluru Bench order sanctioning the Scheme of Arrangement between its wholly owned subsidiary, NH Integrated Care Private Limited, and the parent company, with an appointed date of April 1, 2025. The scheme involves the demerger of 9 clinics in Bengaluru and 1 clinic in Hosur into the main company on a going-concern basis. Since the demerged entity is a wholly owned subsidiary, no new shares will be issued as consideration, leaving the company's share capital unchanged.
How strong was Narayana Hrudayalaya’s trading volume?
1.23 lakh shares traded, 0.73 times the 20-day average daily volume. The price and volume data are dated 13 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.